Edwards Lifesciences Corporation (EW) Earns "Positive" Rating from Northland Securities


's stock had its "positive" rating restated by equities researchers at Northland Securities in a report released on Tuesday. They presently have a $105.00 price target on the medical research company's stock.



from Biotech News